Latest ACUTA CAPITAL PARTNERS, LLC Stock Portfolio
$153Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About ACUTA CAPITAL PARTNERS, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ACUTA CAPITAL PARTNERS, LLC reported an equity portfolio of $153.9 Millions as of 31 Mar, 2024.
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are OCUL, PRAX, MRSN. The fund has invested 15.6% of it's portfolio in OCULAR THERAPEUTIX INC and 6.4% of portfolio in PRAXIS PRECISION MEDICINES I.
The fund managers got completely rid off RAYZEBIO INC, CYMABAY THERAPEUTICS INC (CBAY) and EYEPOINT PHARMACEUTICALS INC (EYPT) stocks. They significantly reduced their stock positions in KURA ONCOLOGY INC. (KURA), CELLECTAR BIOSCIENCES INC. (CLRB) and ARCELLX INC (ACLX). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in AGIOS PHARMA (AGIO), ORIC PHARMACEUTICALS INC (ORIC) and MEREO BIOPHARMA GROUP PLC (MREO). The fund showed a lot of confidence in some stocks as they added substantially to ENLIVEN THERAPEUTICS INC, INSMED INC (INSM) and OCULAR THERAPEUTIX INC (OCUL).
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are OCUL, PRAX, MRSN. The fund has invested 15.6% of it's portfolio in OCULAR THERAPEUTIX INC and 6.4% of portfolio in PRAXIS PRECISION MEDICINES I.
The fund managers got completely rid off RAYZEBIO INC, CYMABAY THERAPEUTICS INC (CBAY) and EYEPOINT PHARMACEUTICALS INC (EYPT) stocks. They significantly reduced their stock positions in KURA ONCOLOGY INC. (KURA), CELLECTAR BIOSCIENCES INC. (CLRB) and ARCELLX INC (ACLX). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in AGIOS PHARMA (AGIO), ORIC PHARMACEUTICALS INC (ORIC) and MEREO BIOPHARMA GROUP PLC (MREO). The fund showed a lot of confidence in some stocks as they added substantially to ENLIVEN THERAPEUTICS INC, INSMED INC (INSM) and OCULAR THERAPEUTIX INC (OCUL).
New Buys
| Ticker | $ Bought |
|---|---|
| AGIOS PHARMA | 1,615,860 |
| ORIC PHARMACEUTICALS INC | 1,429,890 |
| MEREO BIOPHARMA GROUP PLC | 1,313,020 |
| LYRA THERAPEUTICS INC | 1,078,050 |
| ULTRAGENYX PHARMACEUTICAL INC | 933,800 |
| INTRA-CELLULAR THERAPIES INC. | 920,360 |
New stocks bought by ACUTA CAPITAL PARTNERS, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ENLIVEN THERAPEUTICS INC | 219 |
| INSMED INC | 109 |
| OCULAR THERAPEUTIX INC | 101 |
| CELLDEX THERAPEUTICS INC | 57.06 |
| APPLIED THERAPEUTICS INC | 50.83 |
| DYNE THERAPEUTICS INC | 24.8 |
| TOURMALINE BIO INC | 12.6 |
Additions to existing portfolio by ACUTA CAPITAL PARTNERS, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| KURA ONCOLOGY INC. | -87.17 |
| CELLECTAR BIOSCIENCES INC. | -69.95 |
| ARCELLX INC | -55.19 |
| PRAXIS PRECISION MEDICINES I | -45.83 |
| DISC MEDICINE INC | -33.51 |
| VIRIDIAN THERAPEUTICS INC | -29.15 |
| HILLEVAX INC | -22.79 |
| IMMUNOVANT INC | -22.72 |
ACUTA CAPITAL PARTNERS, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| CYMABAY THERAPEUTICS INC | -11,624,700 |
| EYEPOINT PHARMACEUTICALS INC | -9,824,710 |
| RAYZEBIO INC | -23,504,600 |
| AN2 THERAPEUTICS INC | -2,704,680 |
| APELLIS PHARMACEUTICALS INC | -4,555,350 |
| 4D MOLECULAR THERAPEUTICS INC | -1,509,370 |
| CENTESSA PHARMACEUTICALS PLC | -303,578 |
| VERONA PHARMA PLC | -377,720 |
ACUTA CAPITAL PARTNERS, LLC got rid off the above stocks
Current Stock Holdings of ACUTA CAPITAL PARTNERS, LLC
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AADI | AADI BIOSCIENCES INC | 2.81 | 1,849,400 | 4,327,600 | UNCHANGED | 0.00 | |
| ACLX | ARCELLX INC | 1.56 | 34,500 | 2,399,480 | REDUCED | -55.19 | |
| AGIO | AGIOS PHARMA | 1.05 | 55,262 | 1,615,860 | NEW | ||
| ANTX | AN2 THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| APLS | APELLIS PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| APLT | APPLIED THERAPEUTICS INC | 3.50 | 792,000 | 5,385,600 | ADDED | 50.83 | |
| ARGX | ARGENX SE - ADR | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CLDX | CELLDEX THERAPEUTICS INC | 2.97 | 109,000 | 4,574,730 | ADDED | 57.06 | |
| CLRB | CELLECTAR BIOSCIENCES INC. | 0.37 | 143,500 | 571,130 | REDUCED | -69.95 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CRNX | CRINETICS PHARMACEUTICALS | 2.38 | 78,403 | 3,670,040 | REDUCED | -10.4 | |
| DYN | DYNE THERAPEUTICS INC | 3.40 | 184,500 | 5,237,960 | ADDED | 24.8 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| HLVX | HILLEVAX INC | 2.71 | 250,609 | 4,167,630 | REDUCED | -22.79 | |
| IMVT | IMMUNOVANT INC | 1.94 | 92,346 | 2,983,700 | REDUCED | -22.72 | |
| INSM | INSMED INC | 1.09 | 61,718 | 1,674,410 | ADDED | 109 | |
| ITCI | INTRA-CELLULAR THERAPIES INC. | 0.60 | 13,300 | 920,360 | NEW | ||
| KURA | KURA ONCOLOGY INC. | 1.25 | 90,000 | 1,919,700 | REDUCED | -87.17 | |
| LPTX | LEAP THERAPEUTICS INC | 0.61 | 354,166 | 942,082 | UNCHANGED | 0.00 | |
| LYRA | LYRA THERAPEUTICS INC | 0.70 | 173,320 | 1,078,050 | NEW | ||
| MREO | MEREO BIOPHARMA GROUP PLC | 0.85 | 397,884 | 1,313,020 | NEW | ||
| MRSN | MERSANA THERAPEUTICS INC | 6.30 | 2,164,630 | 9,697,530 | REDUCED | -8.59 | |
| NUVB | NUVATION BIO | 0.02 | 90,832 | 27,477 | UNCHANGED | 0.00 | |
| OCUL | OCULAR THERAPEUTIX INC | 15.58 | 2,635,290 | 23,981,100 | ADDED | 101 | |
| ORIC | ORIC PHARMACEUTICALS INC | 0.93 | 103,992 | 1,429,890 | NEW | ||
| PCVX | VAXCYTE INC | 4.65 | 104,830 | 7,160,940 | REDUCED | -10.69 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 6.43 | 162,302 | 9,903,670 | REDUCED | -45.83 | |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.61 | 20,000 | 933,800 | NEW | ||
| RCKT | ROCKET PHARMACEUTICALS INC | 5.72 | 326,787 | 8,803,640 | REDUCED | -10.72 | |
| RVMD | REVOLUTION MEDICINES INC | 3.01 | 143,777 | 4,633,930 | REDUCED | -10.14 | |
| SRPT | SAREPTA THERAPEUTICS INC | 5.40 | 64,162 | 8,306,410 | REDUCED | -9.12 | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| TERN | TERNS PHARMACEUTICALS INC | 1.98 | 465,079 | 3,050,920 | REDUCED | -16.24 | |
| TSHA | TAYSHA GENE THERAPIES INC | 6.21 | 3,333,330 | 9,566,670 | REDUCED | -7.13 | |
| TYRA | TYRA BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2.27 | 199,433 | 3,492,070 | REDUCED | -29.15 | |
| VRNA | VERONA PHARMA PLC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| VSTM | VERASTEM INC | 1.59 | 207,095 | 2,443,720 | REDUCED | -10.83 | |
| ENLIVEN THERAPEUTICS INC | 4.53 | 396,099 | 6,967,380 | ADDED | 219 | ||
| TOURMALINE BIO INC | 3.88 | 261,108 | 5,979,370 | ADDED | 12.6 | ||
| DISC MEDICINE INC | 3.11 | 76,800 | 4,781,570 | REDUCED | -33.51 | ||
| RAYZEBIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |